Accord Healthcare Levothyroxine Sodium Tablets Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Accord Healthcare Inc. is recalling specific lots of Levothyroxine Sodium Tablets, USP, 112 mcg due to subpotent drug.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on September 7, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "Subpotent Drug", distributed nationwide within the united states. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Accord Healthcare, Inc. initiated a voluntary recall of Levothyroxine Sodium Tablets due to subpotent drug.
Which Products Are Affected
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, NDC 16729-452-17. Affected lots are D2402443, D2402444, D2402445 with expiration date 10/31/2026. The recall is nationwide within the United States. Recall number D-0780-2026.
What You Should Do
Consumers should contact their healthcare provider regarding the affected product.
Why This Matters
This Class II recall involves a subpotent prescription thyroid medication distributed nationwide.
Source
FDA recall D-0780-2026, Accord Healthcare, Inc.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (700 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to September 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.